Annual D&A
$6.71 M
+$803.00 K+13.58%
December 31, 2024
Summary
- As of March 14, 2025, KRYS annual depreciation & amortization is $6.71 million, with the most recent change of +$803.00 thousand (+13.58%) on December 31, 2024.
- During the last 3 years, KRYS annual D&A has risen by +$4.87 million (+263.12%).
- KRYS annual D&A is now at all-time high.
Performance
KRYS Depreciation And Amortization Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Related metrics
Quarterly D&A
$1.55 M
+$26.00 K+1.70%
December 31, 2024
Summary
- As of March 14, 2025, KRYS quarterly depreciation & amortization is $1.55 million, with the most recent change of +$26.00 thousand (+1.70%) on December 31, 2024.
- Over the past year, KRYS quarterly D&A has dropped by -$54.00 thousand (-3.36%).
- KRYS quarterly D&A is now -23.06% below its all-time high of $2.02 million, reached on June 30, 2024.
Performance
KRYS Quarterly D&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Related metrics
TTM D&A
$6.71 M
-$202.00 K-2.92%
December 31, 2024
Summary
- As of March 14, 2025, KRYS TTM depreciation & amortization is $6.71 million, with the most recent change of -$202.00 thousand (-2.92%) on December 31, 2024.
- Over the past year, KRYS TTM D&A has increased by +$505.00 thousand (+8.13%).
- KRYS TTM D&A is now -2.92% below its all-time high of $6.92 million, reached on September 30, 2024.
Performance
KRYS TTM D&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Related metrics
KRYS Depreciation And Amortization Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
---|---|---|---|
1 y1 year | +13.6% | -3.4% | +8.1% |
3 y3 years | +263.1% | +271.1% | +98.3% |
5 y5 years | +516.0% | +271.1% | +98.3% |
KRYS Depreciation And Amortization Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
---|---|---|---|---|---|---|---|
3 y | 3-year | at high | +263.1% | -23.1% | +1243.4% | -2.9% | +263.1% |
5 y | 5-year | at high | +516.0% | -23.1% | +1243.4% | -2.9% | +516.0% |
alltime | all time | at high | >+9999.0% | -23.1% | +1243.4% | -2.9% | >+9999.0% |
Krystal Biotech Depreciation And Amortization History
Date | Annual | Quarterly | TTM |
---|---|---|---|
Dec 2024 | $6.71 M(+13.6%) | $1.55 M(+1.7%) | $6.71 M(-2.9%) |
Sep 2024 | - | $1.53 M(-24.3%) | $6.92 M(+2.4%) |
Jun 2024 | - | $2.02 M(+25.6%) | $6.75 M(+8.7%) |
Mar 2024 | - | $1.61 M(-8.4%) | $6.21 M(+5.0%) |
Dec 2023 | $5.91 M(+74.6%) | $1.76 M(+28.7%) | $5.91 M(+29.3%) |
Sep 2023 | - | $1.36 M(-7.6%) | $4.57 M(+9.3%) |
Jun 2023 | - | $1.48 M(+12.7%) | $4.18 M(+13.6%) |
Mar 2023 | - | $1.31 M(+212.9%) | $3.68 M(+8.7%) |
Dec 2022 | $3.38 M(+83.1%) | $419.00 K(-57.0%) | $3.38 M(+19.6%) |
Sep 2022 | - | $975.00 K(-0.1%) | $2.83 M(+7.3%) |
Jun 2022 | - | $976.00 K(-3.8%) | $2.64 M(+13.3%) |
Mar 2022 | - | $1.01 M(-846.3%) | $2.33 M(+25.9%) |
Dec 2021 | $1.85 M(-0.1%) | -$136.00 K(-117.4%) | $1.85 M(-25.3%) |
Sep 2021 | - | $783.00 K(+17.6%) | $2.48 M(+14.1%) |
Jun 2021 | - | $666.00 K(+24.3%) | $2.17 M(+9.8%) |
Mar 2021 | - | $536.00 K(+9.4%) | $1.98 M(+6.7%) |
Date | Annual | Quarterly | TTM |
---|---|---|---|
Dec 2020 | $1.85 M(+69.8%) | $490.00 K(+2.7%) | $1.85 M(+9.0%) |
Sep 2020 | - | $477.00 K(+1.1%) | $1.70 M(+11.6%) |
Jun 2020 | - | $472.00 K(+14.6%) | $1.52 M(+11.1%) |
Mar 2020 | - | $412.00 K(+22.3%) | $1.37 M(+25.7%) |
Dec 2019 | $1.09 M(+673.0%) | $337.00 K(+12.0%) | $1.09 M(+33.9%) |
Sep 2019 | - | $301.00 K(-5.9%) | $814.00 K(+47.7%) |
Jun 2019 | - | $320.00 K(+142.4%) | $551.00 K(+116.1%) |
Mar 2019 | - | $132.00 K(+116.4%) | $255.00 K(+80.9%) |
Dec 2018 | $141.00 K(+513.0%) | $61.00 K(+60.5%) | $141.00 K(+50.0%) |
Sep 2018 | - | $38.00 K(+58.3%) | $94.00 K(+54.1%) |
Jun 2018 | - | $24.00 K(+33.3%) | $61.00 K(+52.5%) |
Mar 2018 | - | $18.00 K(+28.6%) | $40.00 K(+73.9%) |
Dec 2017 | $23.00 K(+1050.0%) | $14.00 K(+180.0%) | $23.00 K(+155.6%) |
Sep 2017 | - | $5000.00(+66.7%) | $9000.00(+125.0%) |
Jun 2017 | - | $3000.00(+200.0%) | $4000.00(+300.0%) |
Mar 2017 | - | $1000.00 | $1000.00 |
Dec 2016 | $2000.00 | - | - |
FAQ
- What is Krystal Biotech annual depreciation & amortization?
- What is the all time high annual D&A for Krystal Biotech?
- What is Krystal Biotech annual D&A year-on-year change?
- What is Krystal Biotech quarterly depreciation & amortization?
- What is the all time high quarterly D&A for Krystal Biotech?
- What is Krystal Biotech quarterly D&A year-on-year change?
- What is Krystal Biotech TTM depreciation & amortization?
- What is the all time high TTM D&A for Krystal Biotech?
- What is Krystal Biotech TTM D&A year-on-year change?
What is Krystal Biotech annual depreciation & amortization?
The current annual D&A of KRYS is $6.71 M
What is the all time high annual D&A for Krystal Biotech?
Krystal Biotech all-time high annual depreciation & amortization is $6.71 M
What is Krystal Biotech annual D&A year-on-year change?
Over the past year, KRYS annual depreciation & amortization has changed by +$803.00 K (+13.58%)
What is Krystal Biotech quarterly depreciation & amortization?
The current quarterly D&A of KRYS is $1.55 M
What is the all time high quarterly D&A for Krystal Biotech?
Krystal Biotech all-time high quarterly depreciation & amortization is $2.02 M
What is Krystal Biotech quarterly D&A year-on-year change?
Over the past year, KRYS quarterly depreciation & amortization has changed by -$54.00 K (-3.36%)
What is Krystal Biotech TTM depreciation & amortization?
The current TTM D&A of KRYS is $6.71 M
What is the all time high TTM D&A for Krystal Biotech?
Krystal Biotech all-time high TTM depreciation & amortization is $6.92 M
What is Krystal Biotech TTM D&A year-on-year change?
Over the past year, KRYS TTM depreciation & amortization has changed by +$505.00 K (+8.13%)